Replies to post #178945 on NorthWest Biotherapeutics Inc (NWBO)

[Ultraz2]

I know, after looking at other companies today, their press releases, and studies updated, I just have to wonder why all the secrecy. I cannot in my heart believe this has been all a ruse, and all these people are involved if the trial is all contrived to earn a select few a few million dollars. Although, I do believe there is value in Direct with further research, most likely after BP buys us out during a fire sale; which just may be what they are and may accomplish if this all continues as it has been. I just don’t get it, why all the secrecy?

[Extremist223]

Assuming she knows 1 2 3 4 5 6

Reasons to not unblind

1) Dcvax-l is not working
2) She's greedy and wanted more shares
3) (Reimbursement) that you guys talk about
4) Make shorts dig a deeper hole for themselves

If she knows 1-6 and dcvax-l is not working, there has to be a way to prove that she knew that it wasn't working and withheld that from us. Don't you think so?

How come AF hasn't officially stated that as one of his problems with NWBO?

Why are they still pretending to be blinded?

How can they possibly know how many were randomized to treatment and placebo?

[scotty3371]

Thank you. Only "regulatators" see blinded results?

[Umibe5690]

With all due respect, LP knows with a good amount of certainty where NWBO stands with the trial. She has a very good idea as to whether the trial met the primary and secondary end points.

After all, she has engaged professional statisticians, has PIs and the SAB, all giving her input. They have more data than anyone except those running the trial. She knows whether or not NWBO has met the primary and secondary endpoints by now.

I believe that NWBO knows that either it is an extremely close call or that they failed. LP has stressed the importance, almost to the exclusion of these end points, of a long and fat tail. This is what investors should be looking for she has continually emphasised. It appears that in order to win reg approvals, broad support from the medical community and insurance coverage, she requires a home run here. They are trying to wring out as much tail as they can and I think LP knows that the spring refresh is her last stand. She won't say it in order to be able to play for time for a miracle hail mary touch down pass. If she delays beyond spring refresh 2018 and goes for a fall and/or 2019 data collection or drags her feet on the current refresh, you know the trial is in trouble. This appears to me to be the reason for all the silence and shifting the responsibility for prolonging the trial on the SAB. JMHO